Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis

Pediatric Pulmonology

Volumn 46, Issue 4, 2011, Pages 385-392

  Dorfman, Ruslan ^a   Taylor, Chelsea ^a   Lin, Fan ^a   Sun, Lei ^b   Sandford, Andrew ^c   Paré, Peter ^c   Berthiaume, Yves ^d   Corey, Mary ^a,b   Durie, Peter ^a,b   Zielenski, Julian ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cystic fibrosis; Infection onset; Lung disease; Pseudomonas aeruginosa; Pulmonary function

Indexed keywords

MANNOSE BINDING LECTIN 2; SODIUM PROTON EXCHANGE PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA1;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INFECTION SENSITIVITY; INTRON; LUNG FUNCTION; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HOMOZYGOTE; HUMANS; INTRONS; LUNG; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SODIUM-HYDROGEN ANTIPORTER;

EID: 79952748854     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21372     Document Type: Article

References (36)

1. Boucher RC. Cystic fibrosis: A disease of vulnerability to airway surface dehydration. Trends Mol Med 2007;13:231-240. (Pubitemid 46836874)
2. + absorption produces cystic fibrosis-like lung disease in mice. Nat Med 2004;10:487-493.
3. Deterding R, Retsch-Bogart G, Milgram L, Gibson R, Daines C, Zeitlin PL, Milla C, Marshall B, Lavange L, Engels J, et al. Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: Results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis. Pediatr Pulmonol 2005;39:339-348. (Pubitemid 40411534)
4. Okada SF, Nicholas RA, Kreda SM, Lazarowski ER, Boucher RC. Physiological regulation of ATP release at the apical surface of human airway epithelia. J Biol Chem 2006;281:22992-23002.
5. Myerburg MM, Butterworth MB, McKenna EE, Peters KW, Frizzell RA, Kleyman TR, Pilewski JM. Airway surface liquid volume regulates ENaC by altering the serine protease-protease inhibitor balance: A mechanism for sodium hyperabsorption in cystic fibrosis. J Biol Chem 2006;281:27942-27949. (Pubitemid 44414506)
6. Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 2006;354:241-250. (Pubitemid 43113029)
7. Quinton PM. Cystic fibrosis: Impaired bicarbonate secretion and mucoviscidosis. Lancet 2008;372:415-417.
8. 2 exposure in rat duodenal mucosa. Am J Physiol Gastrointest Liver Physiol 2008;294:G1318-G1327.
9. Weinman EJ, Cunningham R, Wade JB, Shenolikar S. The role of NHERF-1 in the regulation of renal proximal tubule sodium-hydrogen exchanger 3 and sodium-dependent phosphate cotransporter 2a. J Physiol 2005;567:27-32. (Pubitemid 41167300)
10. Zachos NC, Tse M, Donowitz M. Molecular physiology of intestinal Na+/H+ exchange. Annu Rev Physiol 2005;67:411-443. (Pubitemid 40409511)
11. Hihnala S, Kujala M, Toppari J, Kere J, Holmberg C, Hoglund P. Expression of SLC26A3, CFTR and NHE3 in the human male reproductive tract: Role in male subfertility caused by congenital chloride diarrhoea. Mol Hum Reprod 2006;12:107-111.
12. Kujala M, Hihnala S, Tienari J, Kaunisto K, Hastbacka J, Holmberg C, Kere J, Hoglund P. Expression of ion transport-associated proteins in human efferent and epididymal ducts. Reproduction 2007;133:775-784. (Pubitemid 46831902)
13. Furukawa O, Bi LC, Guth PH, Engel E, Hirokawa M, Kaunitz JD. NHE3 inhibition activates duodenal bicarbonate secretion in the rat. Am J Physiol Gastrointest Liver Physiol 2004;286:G102-G109. (Pubitemid 38055843)
14. + absorption increases survival and decreases the incidence of intestinal obstructions in cystic fibrosis mice. Am J Physiol Gastrointest Liver Physiol 2009;296:G886-G898.
15. Lohi H, Lamprecht G, Markovich D, Heil A, Kujala M, Seidler U, Kere J. Isoforms of SLC26A6 mediate anion transport and have functional PDZ interaction domains. Am J Physiol Cell Physiol 2003;284:C769-C779. (Pubitemid 36237529)
16. Dorfman R, Sandford A, Taylor C, Huang B, Frangolias D, Wang Y, Sang R, Pereira L, Sun L, Berthiaume Y, et al. Complex two-gene modulation of lung disease severity in children with cystic fibrosis. J Clin Invest 2008;118:1040-1049. (Pubitemid 351364611)
17. Kristidis P, Bozon D, Corey M, Markiewicz D, Rommens J, Tsui LC, Durie P. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet 1992;50:1178-1184.
18. Ahmed N, Corey M, Forstner G, Zielenski J, Tsui LC, Ellis L, Tullis E, Durie P. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 2003;52:1159-1164. (Pubitemid 36877429)
19. Taylor, J.D. Briley, D. Nguyen, Q. Long, K. Iannone, M.A. Li, M.S. Ye, F. Afshari, A. Lai, E. Wagner, M. Chen, J. Weiner, M.P. Flow cytometric platform for high-throughput single nucleotide polymorphism analysis. Biotechniques 2001;30:661-669.
20. Ye F, Li MS, Taylor JD, Nguyen Q, Colton HM, Casey WM, Wagner M, Weiner MP, Chen J. Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification. Hum Mutat 2001;17:305-316. (Pubitemid 32268406)
21. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, Svejgaard A. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995;155:3013-3020.
22. Wang SS, O'Leary LA, Fitzsimmons SC, Khoury MJ. The impact of early cystic fibrosis diagnosis on pulmonary function in children. J Pediatr 2002;141:804-810. (Pubitemid 35471642)
23. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187. (Pubitemid 29036522)
24. Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D. Cystic fibrosis adult care: Consensus conference report. Chest 2004;125:1S-39S.
25. Schluchter MD, Konstan MW, Drumm ML, Yankaskas JR, Knowles MR. Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data. Am J Respir Crit Care Med 2006;174:780-786. (Pubitemid 44511659)
26. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, et al. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005; 353:1443-1453. (Pubitemid 41400918)
27. + exchanger isoform 3 in a renal polarized epithelial cell model. J Biol Chem 2002;277:21480-21488.
28. Favia M, Fanelli T, Bagorda A, Di Sole F, Reshkin SJ, Suh PG, Guerra L, Casavola V. NHE3 inhibits PKA-dependent functional expression of CFTR by NHERF2 PDZ interactions. Biochem Biophys Res Commun 2006;347:452-459.
29. Wheat VJ, Shumaker H, Burnham C, Shull GE, Yankaskas JR, Soleimani M. CFTR induces the expression of DRA along with Cl(-)/HCO(3)(-) exchange activity in tracheal epithelial cells. Am J Physiol Cell Physiol 2000;279:C62-C71.
30. 3- exchange by slc26a3 and slc26a6. J Gen Physiol 2006; 127:511-524.
31. 3-secretion: Relevance to cystic fibrosis. EMBO J 2006;25:5049-5057.
32. 3-deficient mice: Evidence for spontaneous distal colitis. Am J Physiol Gastrointest Liver Physiol 2008.
33. Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M, Auerbach W, Moore A, Forstner J, Durie P, Nadeau J, et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet 1996;12:280-287. (Pubitemid 26080087)
34. Ratjen F. Changes in strategies for optimal antibacterial therapy in cystic fibrosis. Int J Antimicrob Agents 2001;17:93-96. (Pubitemid 32103283)
35. Hropot M, Juretschke HP, Langer KH, Schwark JR. S3226, a novel NHE3 inhibitor, attenuates ischemia-induced acute renal failure in rats. Kidney Int 2001;60:2283-2289.
36. Wiemann M, Piechatzek L, Gopelt K, Kiwull-Schone H, Kiwull P, Bingmann D. The NHE3 inhibitor AVE1599 stimulates phrenic nerve activity in the rat. J Physiol Pharmacol 2008;59: 27-36. (Pubitemid 351520160)